glp-1 inhibitor Glucagon-like peptide-1 Mechanisms of action of GLP-1RA.
Description
55 pM for GLP-1 in one cellular assay (99)
The drugs that will be available in five years will likely make todays standard of care look like what metformin looks like next to tirzepatide
Back Seery, C (15 Jan 2019) 'DPP-4 inhibitors (Gliptins)'
This is a genuinely clinical evidence base but it is phase-2/phase-3 investigational data, not a finished, approved product
